z-logo
open-access-imgOpen Access
Towards a multi‐marker prognostic strategy in acute heart failure: a role for GDF‐15
Author(s) -
Bettencourt Paulo,
FerreiraCoimbra João,
Rodrigues Pedro,
Marques Pedo,
Moreira Helena,
Pinto Maria João,
Guimarães João Tiago,
Lourenço Patrícia
Publication year - 2018
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.12301
Subject(s) - medicine , gdf15 , heart failure , hazard ratio , ejection fraction , cardiology , proportional hazards model , natriuretic peptide , brain natriuretic peptide , biomarker , multivariate analysis , confidence interval , biochemistry , chemistry
Aims Growth differentiation factor (GDF)‐15 mirrors inflammation and oxidative stress in cardiovascular diseases. Brain natriuretic peptide (BNP) is associated with cardiomyocyte stretch in heart failure (HF). The objective of this study was to evaluate the prognostic impact of plasma GDF‐15 and BNP in acute HF. Methods and results We studied a subgroup of patients prospectively recruited in an acute HF registry (follow‐up: 2 years; endpoint: all‐cause mortality). Cox regression multivariate models were built to study the association of GDF‐15 and mortality. Further cross‐classification according to discharge GDF‐15 (mean) and BNP (mean) and association with mortality was studied. We studied 158 patients: seventy‐nine were male, mean age was 75 years, 55.1% had left ventricular ejection fraction < 40%, mean discharge BNP was 1000 pg/mL, and mean GDF‐15 was 3013 ng/mL. Higher BNP and GDF‐15 predicted 2‐year mortality. Patients with GDF‐15 ≥ 3000 ng/mL had a multivariate adjusted 2‐year death risk of 1.86 (1.08–3.18). Patients discharged with both BNP and GDF‐15 above the mean had an adjusted hazard ratio of 4.33 (2.07–9.06) when compared with those with both

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here